Tirosint leaving MDRP 10.01.24

Tirosint leaving MDRP 10.01.24

Effective October 1, 2024, the manufacturers Ibsa Pharma Inc. and Yaral Pharma Inc have chosen to no longer be part of the Medicaid Drug Rebate Program (MDRP). Both Ibsa Pharma Inc. and Yaral Pharma Inc. manufacture levothyroxine products along with other agents. As a result, MO HealthNet will no longer be able to pay claims for these manufacturer's products for dates of service on and after October 1, 2024.

Notification of Pregnancy and Risk Assessment Webinars

New Notification of Pregnancy and Risk Screening Webinars

Effective November 1, 2024, MO HealthNet enrolled providers (including Fee-For-Service (FFS) and Managed Care (MC) Health Plan providers) who provide obstetric care/services, primary care, and emergency care to MO HealthNet participants can begin utilizing the new NOP and Risk Screening Portal to notify the MO HealthNet Division (MHD) and the&n

MissouriBUYS Bid Opportunity

MissouriBUYS Bid Opportunity

The State of Missouri has issued a bid opportunity in the MissouriBUYS Statewide eProcurement System that may be of interest to you. The bid will close on October 8, 2024 at 2:00 pm.

Solicitation/Opportunity No: RFPS30034902500279
Solicitation/Opportunity Description: Long-Term Care Rebalancing Opportunities 
State Agency: Department of Health and Senior Services